Evaluating the Impact of an mHealth Platform for Managing Acute Postoperative Dental Pain: Randomized Controlled Trial.

PRO PROM PROs RCT acute pain dental dentist dentistry mHealth mobile health pain patient-reported outcome patient-reported outcome measures patient-reported outcomes randomized controlled trial

Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
20 Oct 2023
Historique:
received: 05 06 2023
revised: 17 07 2023
accepted: 21 07 2023
medline: 8 11 2023
pubmed: 7 11 2023
entrez: 7 11 2023
Statut: epublish

Résumé

Postoperative dental pain is pervasive and can affect a patient's quality of life. Adopting a patient-centric approach to pain management involves having contemporaneous information about the patient's experience of pain and using it to personalize care. In this study, we evaluated the use of a mobile health (mHealth) platform to collect pain-related patient-reported outcomes over 7 days after the patients underwent pain-inducing dental procedures; we then relayed the information to the dentist and determined its impact on the patient's pain experience. The study used a cluster-randomized experimental study design with an intervention arm where patients were prompted to complete a series of questions relating to their pain experience after receiving automated text notifications on their smartphone on days 1, 3, 5, and 7, with the resulting information fed back to dentists, and a control arm where patients received usual care. Providers were randomized, and patients subsequently assumed the enrollment status of their providers. Providers or their staff identified eligible patients and invited them to participate in the study. Provider interviews and surveys were conducted to evaluate acceptance of the mHealth platform. A total of 42 providers and 1525 patients participated. For the primary outcome (pain intensity on a 1 to 10 scale, with 10 being the most painful), intervention group patients reported an average pain intensity of 4.8 (SD 2.6), while those in the control group reported an average pain intensity of 4.7 (SD 2.8). These differences were not significant. There were also no significant differences in secondary outcomes, including pain interference with activity or sleep, patient satisfaction with pain management, or opioid prescribing. Patient surveys revealed reluctance to use the app was mostly due to technological challenges, data privacy concerns, and a preference for phone calls over texting. Providers had high satisfaction with the app and suggested integrating additional features, such as an in-system camera for patients to upload pictures and videos of the procedural site, and integration with the electronic health record system. While the mHealth platform did not have a significant impact on acute postoperative pain experience, patients and providers indicated improvement in patient-provider communication, patient-provider relationship, postoperative complication management, and ability to manage pain medication prescribing. Expanded collaboration between mHealth developers and frontline health care providers can facilitate the applicability of these platforms, further help improve its integration with the normal clinic workflow, and assist in moving toward a more patient-centric approach to pain management.

Sections du résumé

Background UNASSIGNED
Postoperative dental pain is pervasive and can affect a patient's quality of life. Adopting a patient-centric approach to pain management involves having contemporaneous information about the patient's experience of pain and using it to personalize care.
Objective UNASSIGNED
In this study, we evaluated the use of a mobile health (mHealth) platform to collect pain-related patient-reported outcomes over 7 days after the patients underwent pain-inducing dental procedures; we then relayed the information to the dentist and determined its impact on the patient's pain experience.
Methods UNASSIGNED
The study used a cluster-randomized experimental study design with an intervention arm where patients were prompted to complete a series of questions relating to their pain experience after receiving automated text notifications on their smartphone on days 1, 3, 5, and 7, with the resulting information fed back to dentists, and a control arm where patients received usual care. Providers were randomized, and patients subsequently assumed the enrollment status of their providers. Providers or their staff identified eligible patients and invited them to participate in the study. Provider interviews and surveys were conducted to evaluate acceptance of the mHealth platform.
Results UNASSIGNED
A total of 42 providers and 1525 patients participated. For the primary outcome (pain intensity on a 1 to 10 scale, with 10 being the most painful), intervention group patients reported an average pain intensity of 4.8 (SD 2.6), while those in the control group reported an average pain intensity of 4.7 (SD 2.8). These differences were not significant. There were also no significant differences in secondary outcomes, including pain interference with activity or sleep, patient satisfaction with pain management, or opioid prescribing. Patient surveys revealed reluctance to use the app was mostly due to technological challenges, data privacy concerns, and a preference for phone calls over texting. Providers had high satisfaction with the app and suggested integrating additional features, such as an in-system camera for patients to upload pictures and videos of the procedural site, and integration with the electronic health record system.
Conclusions UNASSIGNED
While the mHealth platform did not have a significant impact on acute postoperative pain experience, patients and providers indicated improvement in patient-provider communication, patient-provider relationship, postoperative complication management, and ability to manage pain medication prescribing. Expanded collaboration between mHealth developers and frontline health care providers can facilitate the applicability of these platforms, further help improve its integration with the normal clinic workflow, and assist in moving toward a more patient-centric approach to pain management.

Identifiants

pubmed: 37933185
pii: v11i1e49677
doi: 10.2196/49677
pmc: PMC10644946
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e49677

Subventions

Organisme : AHRQ HHS
ID : U18 HS026135
Pays : United States

Informations de copyright

© Bunmi Tokede, Alfa Yansane, Ana Ibarra-Noriega, Joanna Mullins, Kristen Simmons, Nicholas Skourtes, Urvi Mehta, Sayali Tungare, David Holmes, Joel White, Muhammad Walji, Elsbeth Kalenderian. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org).

Références

J Am Dent Assoc. 2016 Oct;147(10):782-791.e1
pubmed: 27206728
Cureus. 2022 Jul 26;14(7):e27299
pubmed: 35903483
BMC Med Inform Decis Mak. 2020 Feb 10;20(1):27
pubmed: 32041608
J Pain Res. 2017 Sep 25;10:2287-2298
pubmed: 29026331
BMC Public Health. 2016 Nov 14;16(1):1158
pubmed: 27842533
Pain. 2003 Jul;104(1-2):187-94
pubmed: 12855328
Healthcare (Basel). 2021 Mar 22;9(3):
pubmed: 33809828
Nurse Res. 2011;18(2):52-62
pubmed: 21319484
Transl Behav Med. 2017 Jun;7(2):254-267
pubmed: 27966189
JMIR Mhealth Uhealth. 2018 Nov 29;6(11):e10123
pubmed: 30497999
Isr J Health Policy Res. 2021 Mar 5;10(1):21
pubmed: 33673875
Int J Environ Res Public Health. 2022 Jun 14;19(12):
pubmed: 35742541
J Med Internet Res. 2017 Aug 24;19(8):e295
pubmed: 28838887
Med Care. 2007 May;45(5 Suppl 1):S3-S11
pubmed: 17443116
J Am Dent Assoc. 2016 Jul;147(7):530-3
pubmed: 27350643
JMIR Mhealth Uhealth. 2020 Jul 8;8(7):e16365
pubmed: 32673235
J Am Dent Assoc. 2021 Apr;152(4):309-317
pubmed: 33637299
J Am Dent Assoc. 2018 Dec;149(12):1011-1023
pubmed: 30205900
JMIR Mhealth Uhealth. 2018 Oct 22;6(10):e11231
pubmed: 30348633
Adv Radiat Oncol. 2021 Jan-Feb;6(1):100576
pubmed: 33073061
BMC Oral Health. 2022 Dec 9;22(1):581
pubmed: 36494795
Oral Maxillofac Surg. 2021 Dec;25(4):549-559
pubmed: 33761022
JMIR Mhealth Uhealth. 2021 Mar 4;9(3):e21795
pubmed: 33661123
Int J Environ Res Public Health. 2022 Oct 01;19(19):
pubmed: 36231862
Am J Prev Med. 2022 Jul;63(1):3-12
pubmed: 35232618
Br Dent J. 2015 Aug 28;219(4):E2
pubmed: 26315196
JMIR Mhealth Uhealth. 2020 Jan 23;8(1):e17055
pubmed: 32012088
J Pain. 2010 Nov;11(11):1172-86
pubmed: 20400379
Science. 1987 Apr 10;236(4798):157-61
pubmed: 3563494
J Pain. 2012 Aug;13(8):715-24
pubmed: 22607834
J Med Radiat Sci. 2021 Jun;68(2):186-195
pubmed: 32815314
J Mob Technol Med. 2015 Jan 1;4(1):25-30
pubmed: 25729441
Int J Nurs Stud. 2023 Feb;138:104409
pubmed: 36527860
J Med Internet Res. 2021 May 25;23(5):e24190
pubmed: 34032583
Stud Health Technol Inform. 2009;149:93-102
pubmed: 19745474
JMIR Mhealth Uhealth. 2021 Jan 13;9(1):e19958
pubmed: 33439141
J Med Internet Res. 2018 Jul 19;20(7):e10940
pubmed: 30026178
Br J Oral Maxillofac Surg. 1985 Dec;23(6):410-8
pubmed: 2933061

Auteurs

Bunmi Tokede (B)

The University of Texas Health Science Center, Houston, TX, United States.

Alfa Yansane (A)

School of Dentistry, University of California San Francisco, San Francisco, CA, United States.

Ana Ibarra-Noriega (A)

The University of Texas Health Science Center, Houston, TX, United States.

Joanna Mullins (J)

Willamette Dental Group, Hillsboro, OR, United States.

Kristen Simmons (K)

Willamette Dental Group, Hillsboro, OR, United States.

Nicholas Skourtes (N)

Willamette Dental Group, Hillsboro, OR, United States.

Urvi Mehta (U)

The University of Texas Health Science Center, Houston, TX, United States.

Sayali Tungare (S)

The University of Texas Health Science Center, Houston, TX, United States.

David Holmes (D)

FollowApp.Care, London, United Kingdom.

Joel White (J)

School of Dentistry, University of California San Francisco, San Francisco, CA, United States.

Muhammad Walji (M)

The University of Texas Health Science Center, Houston, TX, United States.

Elsbeth Kalenderian (E)

School of Dentistry, University of California San Francisco, San Francisco, CA, United States.
Harvard School of Dental Medicine, Boston, MA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH